Showing results (41-50 of 340) with videos related to
Sort By:
Pageof 34
The Kaohsiung Journal of Medical Sciences|March 3, 2021
Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinomaZu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.The Kaohsiung Journal of Medical Sciences|February 10, 2022
Limited sorafenib anticancer effects on primary cultured hepatocellular carcinoma cells with high NANOG expressionZu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.The Kaohsiung Journal of Medical Sciences|January 21, 2015
Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilutionTa-Wei Liu, Ming-Lun Yeh, Chung-Feng Huang, et al.The Kaohsiung Journal of Medical Sciences|September 27, 2025
Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of ColchicineZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.The Kaohsiung Journal of Medical Sciences|April 11, 2022
The compound annual growth rate of the fibrosis-4 index in chronic hepatitis B patientsTa-Wei Liu, Chung-Feng Huang, Pei-Chien Tsai, et al.Journal of Gastroenterology and Hepatology|October 13, 2017
Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapyChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.BMJ Open Gastroenterology|December 16, 2020
Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 IndexTa-Wei Liu, Chung-Feng Huang, Ming-Lun Yeh, et al.Cancers|October 28, 2023
Dose Consideration of Lenvatinib's Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine TherapyZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.Antiviral Research|June 16, 2004
A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factorsMing-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, et al.Medicine|March 26, 2016
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese PatientsChi-Ming Tai, Chih-Kun Huang, Hung-Pin Tu, et al.Pageof 34